The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Pharmacological Reviews2006Vol. 58(3), pp. 463–487
Citations Over TimeTop 1% of 2006 papers
Nan Chiang, Charles N. Serhan, Sven‐Erik Dahlén, Jeffrey M. Drazen, Douglas W.P. Hay, G. Enrico Rovati, Takao Shimizu, Takehiko Yokomizo, Charles Brink
Related Papers
- → Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution(2005)454 cited
- → Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A4(2013)50 cited
- → What Formyl Peptide Receptors, if Any, Are Triggered by Compound 43 and Lipoxin A4?(2011)47 cited
- → Lipoxin A4 Metabolites/Analogues from Two Commercial Sources have No Effects on TNF‐α‐mediated Priming or Activation through the Neutrophil Formyl Peptide Receptors(2009)39 cited
- → 15‐epi‐lipoxin A 5 promotes neutrophil exit from exudates for clearance by splenic macrophages(2024)7 cited